Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 02 October 2025
      Blogs
 
  02 October 2025 From half measures to full ambition: building a world-class regulatory framework

Europe’s pharma reform is an opportunity to strengthen resilience, speed up access to medicines, and secure our place...

Read more →
 
 
 
      How the EU Cardiovascular Health Plan could transform health in Europe

Cardiovascular disease is the number one killer in Europe, responsible for 1 in 3 deaths and affecting more than 60 million people.

The EU Cardiovascular Health Plan represents a key opportunity to change course. From prevention, to care to cure, it offers the chance to improve outcomes for people living with or at risk of CVD.

By implementing health checks, people with risk of CVD will get the treatment and care they need in time, preventing severe disease and deaths. The EU CVH Plan should also focus on improving adherence to treatment, supporting research and innovation, and better using data and digital tools. It should help create a future in which people live longer, healthier lives. Imagine what that would mean for patients, families, and for Europe.

Discover more here. 

 
 
 
      Events
 
 
06 OCT 2025
  Biotech Business Mission to Japan 2025 - Call for applications Osaka & Yokohama, Japan

Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation....

Learn more →
 
 
 
07 OCT 2025
  Healthcare Ethics & Compliance Conference “HETHICO” The Hotel, Brussels

​​After a successful HETHICO 2024, we are excited to announce the next edition!

Learn more →
 
 
 
31 OCT 2025
  Trials@Home Closing Event 2025 Utrecht, Hybrid

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring...

Learn more →
 
 
 
04 NOV 2025
  IHI Brokerage Event 2025 Brussels, Belgium

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and...

Learn more →
 
 
      What we are reading
New project EuroHeartPath sets out plans to transform cardiovascular care 29 September 2025  (IHI) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe